Non-Invasive Low Pulsed Electrical Fields for Inducing BBB Disruption in Mice—Feasibility Demonstration
Shirley Sharabi
David Last
Dianne Daniels
Ido Didi Fabian
Dana Atrakchi
Yael Bresler
Sigal Liraz-Zaltsman
Itzik Cooper
Yael Mardor
Pharmaceutics, 2021-1-27
Ido Didi Fabian
Fabian Ido Didi
/ Didi
ORCID: 0000-0002-0846-5131
The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey
10.3390/cancers13194773
A conjunctival and choroidal melanoma in the same eye: report of two cases
10.1007/s00417-017-3609-x
Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes
10.1016/j.ajo.2017.05.003
Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye
10.1136/bjophthalmol-2017-310624
Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma
10.1016/j.ajo.2017.06.025
Focal laser treatment in addition to chemotherapy for retinoblastoma.
10.1002/14651858.cd012366.pub2
Subretinal Hemorrhage Associated with Astrocytic Hamartoma.
10.1016/j.ophtha.2016.10.013
Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma.
10.1038/eye.2017.22
High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
10.1016/j.ophtha.2017.01.048
Diagnosis and management of secondary epipapillary retinoblastoma.
10.1136/bjophthalmol-2016-309899
Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma.
10.1093/bmb/ldw053
Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis.
10.1136/bjophthalmol-2016-309710
Outcomes of Scleral Buckle Removal: Experience from the Last Decade.
10.1080/02713683.2016.1245423
Evicel versus Tisseel versus Sutures for Attaching Conjunctival Autograft in Pterygium Surgery: A Prospective Comparative Clinical Study.
10.1016/j.ophtha.2016.09.010
Extremely Invasive Conjunctival Melanoma.
10.1016/j.ophtha.2016.04.030
Alveolar Rhabdomyosarcoma of the foot metastasizing to the Iris: report of a rare case.
10.1186/s12885-016-2496-6
MALIGNANT TRANSFORMATION OF A CHOROIDAL NEVUS IN AN EYE TREATED FOR CHOROIDAL MELANOMA.
10.1097/icb.0000000000000311
Acute Optic Neuropathy and Development of Posttraumatic Stress Disorder.
10.3109/08820538.2015.1115086
A Biological Tissue Adhesive and Dissolvent System for Intraocular Tumor Plaque Brachytherapy.
10.3928/23258160-20160126-10
A Suspected Choroidal Melanoma With Extraocular Extension in Pregnancy.
10.1001/jamaophthalmol.2015.3619
Comparison of lateral orbital decompression with and without rim repositioning in thyroid eye disease.
10.1007/s00417-015-3237-2
Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis.
10.1016/j.ajo.2015.08.034
Primary Vitreoretinal Lymphoma Masquerading as Refractory Retinitis.
10.1159/000440762
Erratum to: A biological tissue adhesive and dissolvent system for intraocular tumor plaque radiotherapy: an in vivo animal model experiment.
10.1007/s00417-015-3164-2
Letter to the editor.
10.1016/j.survophthal.2015.08.001
A biological tissue adhesive and dissolvent system for intraocular tumor plaque radiotherapy: an in vivo animal model experiment.
10.1007/s00417-015-3082-3
Measurement of Axial Length in an Office Setting Versus Under General Anesthesia in Infants and Toddlers: A Comparative Study.
10.3928/01913913-20150602-02
Periocular pilomatrixoma: a retrospective analysis of 16 cases.
10.1097/iop.0000000000000164
Reply: To PMID 23514799.
10.1097/iae.0000000000000031
The possible association of attention deficit hyperactivity disorder with undiagnosed refractive errors.
10.1016/j.jaapos.2013.06.005
Complications of pneumatic retinopexy--reply.
10.1001/jamaophthalmol.2013.5371
Prognostic factors and visual outcomes of ruptured and lacerated globe injuries.
10.5301/ejo.5000364
Outcomes of repeated pars plana vitrectomy for persistent macular holes.
10.1097/iae.0b013e31828076c5
Congenital ptosis repair-surgical, cosmetic, and functional outcome: a report of 162 cases.
10.1016/j.jcjo.2012.09.010
Pneumatic retinopexy for the repair of primary rhegmatogenous retinal detachment: a 10-year retrospective analysis.
10.1001/2013.jamaophthalmol.361
Diagnosis of posttraumatic stress disorder after surgery for primary rhegmatogenous retinal detachment.
10.1097/iae.0b013e31825d7ea4
Abnormal vertical angle kappa caused by ectopic fovea.
10.1016/j.jaapos.2012.07.006
Strabismus after inferior-medial wall orbital decompression in thyroid-related orbitopathy.
10.3109/02713683.2012.713154
Macular hole after vitrectomy for primary rhegmatogenous retinal detachment.
10.1097/iae.0b013e31821f5d81
Bilateral presumed astrocytic hamartomas in a patient with retinitis pigmentosa.
10.2147/opth.s23970
Comparison of pars plana vitrectomy with and without scleral buckle for the repair of primary rhegmatogenous retinal detachment.
10.1016/j.ajo.2011.01.049
Intraocular pressure measurements and biomechanical properties of the cornea in eyes after penetrating keratoplasty.
10.1016/j.ajo.2010.11.007
Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma.
10.1016/j.ajo.2010.07.022
Chiasmal stroke following open-heart surgery.
10.1097/wno.0b013e3181e4de97
Sutureless vitrectomy: evolution and current practices.
10.1136/bjo.2009.176495
Conjunctival ulceration in Behçet disease: a case report.
10.1136/bcr.08.2008.0616
Cataract extraction without prophylactic treatment in patients with severe factor XI deficiency.
10.1016/j.ajo.2009.07.013
Primary photodynamic therapy with verteporfin for pigmented posterior pole cT1a choroidal melanoma: a 3-year retrospective analysis
10.1136/bjophthalmol-2017-311747
Do no harm: Observation only in a 98-year-old woman with a suspicious large intraocular tumour
10.1016/j.ajoc.2018.03.011
Examinations under anaesthesia as a measure of disease burden in unilateral retinoblastoma: the London experience
10.1136/bjophthalmol-2018-313556
Response to “Two Uveal Melanomas in One Eye: A Choroidal Nevus Giving Rise to a Melanoma in an Eye with a Separate Large Choroidal Melanoma”
10.1159/000497615
Development of conjunctival intraepithelial neoplasia following phototherapy for mycosis fungoides
10.1016/j.ajoc.2019.03.012
Number, frequency and time interval of examinations under anesthesia in bilateral retinoblastoma
10.1007/s00417-019-04589-4
Retinoblastoma presentation, treatment and outcome in a large referral centre in Tehran: a 10-year retrospective analysis
10.1038/s41433-020-0907-z
Retinoblastoma management during the COVID‐19 pandemic: A report by the Global Retinoblastoma Study Group including 194 centers from 94 countries
10.1002/pbc.28584
Long term outcomes of small pigmented choroidal melanoma treated with primary photodynamic therapy
10.1016/j.oret.2020.08.019
Adjuvant use of laser in eyes with macular retinoblastoma treated with primary intravenous chemotherapy
10.1136/bjophthalmol-2020-316862
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries
10.1016/j.ophtha.2021.01.024
Non-Invasive Low Pulsed Electrical Fields for Inducing BBB Disruption in Mice—Feasibility Demonstration
10.3390/pharmaceutics13020169
Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries
10.3390/cancers13081956
Retinal Vascular Signs as Screening and Prognostic Factors for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Current Evidence
10.3390/jpm11070665
Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countries
10.1038/s41433-021-01675-y
itzik cooper
cooper itzik
ORCID: 0000-0003-0723-5542
Caspase-1: an important player and possible target for repair of the blood-brain barrier underlying neurodegeneration.
10.4103/1673-5374.313031
Endothelial Iron Homeostasis Regulates Blood-Brain Barrier Integrity via the HIF2α-Ve-Cadherin Pathway.
10.3390/pharmaceutics13030311
Dietary alpha linolenic acid in pregnant mice and during weaning increases brain docosahexaenoic acid and improves recognition memory in the offspring.
10.1016/j.jnutbio.2021.108597
Non-Invasive Low Pulsed Electrical Fields for Inducing BBB Disruption in Mice-Feasibility Demonstration.
10.3390/pharmaceutics13020169
Naphthoquinone-Dopamine Hybrids Inhibit α-Synuclein Aggregation, Disrupt Preformed Fibrils, and Attenuate Aggregate-Induced Toxicity.
10.1002/chem.202003374
Caspase-1 has a critical role in blood-brain barrier injury and its inhibition contributes to multifaceted repair.
10.1186/s12974-020-01927-w
The application of point source electroporation and chemotherapy for the treatment of glioma: a randomized controlled rat study.
10.1038/s41598-020-59152-7
Transient blood-brain barrier disruption is induced by low pulsed electrical fields in vitro: an analysis of permeability and trans-endothelial electric resistivity.
10.1080/10717544.2019.1571123
TCF7L2 polymorphisms are associated with amygdalar volume in elderly individuals with Type 2 Diabetes.
10.1038/s41598-019-48899-3
Converting bleomycin into a prodrug that undergoes spontaneous reactivation under physiological conditions.
10.1016/j.taap.2019.114782
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer's disease-like symptoms in animal model.
10.1007/s00018-019-03312-0
Blood-Brain Barrier Cellular Responses Toward Organophosphates: Natural Compensatory Processes and Exogenous Interventions to Rescue Barrier Properties.
10.3389/fncel.2018.00359
High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse model.
10.1111/acel.12818
Haptoglobin 1-1 Genotype Modulates the Association of Glycemic Control With Hippocampal Volume in Elderly Individuals With Type 2 Diabetes.
10.2337/db16-0987
Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations.
10.1371/journal.pone.0158352
Long-term Variability in Glycemic Control Is Associated With White Matter Hyperintensities in APOE4 Genotype Carriers With Type 2 Diabetes.
10.2337/dc15-2331
High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model.
10.1111/acel.12436
Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway.
10.1007/s00702-015-1446-9
Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.
10.1016/j.euroneuro.2015.11.004
Combined Treatment of an Amyotrophic Lateral Sclerosis Rat Model with Recombinant GOT1 and Oxaloacetic Acid: A Novel Neuroprotective Treatment.
10.1159/000382034
Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.
10.1038/jcbfm.2015.6
Blood methylomic signatures of presymptomatic dementia in elderly subjects with type 2 diabetes mellitus.
10.1016/j.neurobiolaging.2014.12.023
The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes.
10.1016/j.euroneuro.2014.06.002
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.
10.1007/s10637-012-9799-5
Peptide derived from HIV-1 TAT protein destabilizes a monolayer of endothelial cells in an in vitro model of the blood-brain barrier and allows permeation of high molecular weight proteins.
10.1074/jbc.m112.395384
Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas.
10.1007/s10637-012-9794-x
Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells.
10.1038/jcbfm.2011.121
Interactions of the prion peptide (PrP 106-126) with brain capillary endothelial cells: coordinated cell killing and remodeling of intercellular junctions.
10.1111/j.1471-4159.2010.06934.x
Claudin-5 expression in in vitro models of the blood-brain barrier.
10.1007/978-1-61779-185-7_25
Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness.
10.1016/j.brainres.2009.05.072
Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.
10.1080/10428190902878448
Yael Mardor
Mardor Yael
ORCID: 0000-0002-8561-8875
Non-Invasive Low Pulsed Electrical Fields for Inducing BBB Disruption in Mice—Feasibility Demonstration
10.3390/pharmaceutics13020169
shirley sharabi
sharabi shirley
ORCID: 0000-0002-1561-7965
Effect of electroporation on blood-brain barrier
10.1007/978-3-319-32886-7_168
Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors
10.1038/jcbfm.2015.6
Dynamic effects of point source electroporation on the rat brain tissue
10.1016/j.bioelechem.2014.06.001
Magnetic resonance imaging depiction of non thermal irreversible electroporation treated liver
10.1007/978-3-319-11128-5_209
MRI study on reversible and irreversible electroporation induced blood brain barrier disruption
10.1371/journal.pone.0042817
Liposomal temozolomide drug delivery using convection enhanced delivery
10.1016/j.jconrel.2017.06.028
A statistical model describing combined irreversible electroporation and electroporation-induced blood-brain barrier disruption
10.1515/raon-2016-0009
Non-thermal focused ultrasound induced reversible reduction of essential tremor in a rat model
10.1016/j.brs.2018.08.014
The effect of blood flow on magnetic resonance imaging of non thermal irreversible electroporation
10.1038/srep03088
Focused Ultrasound-Induced Suppression of Auditory Evoked Potentials in Vivo
10.1016/j.ultrasmedbio.2018.01.010
Transient blood–brain barrier disruption is induced by low pulsed electrical fields in vitro: an analysis of permeability and trans-endothelial electric resistivity
10.1080/10717544.2019.1571123
The application of point source electroporation and chemotherapy for the treatment of glioma: a randomized controlled rat study
10.1038/s41598-020-59152-7
The effects of point-source electroporation on the blood-brain barrier and brain vasculature in rats: An MRI and histology study.
10.1016/j.bioelechem.2020.107521
A Novel Compound Targeting Protease Receptor 1 Activators for the Treatment of Glioblastoma.
10.3389/fneur.2018.01087
Radiation-induced vascular malformations in the brain, mimicking tumor in MRI-based treatment response assessment maps (TRAMs).
10.1016/j.ctro.2018.11.004
NIMG-35. TREATMENT RESPONSE ASSESSMENT MAPS (TRAMs) SENSITIVITY TO TUMOR/TREATMENT-EFFECTS AS A FUNCTION OF DATA ACQUISITION PARAMETERS.
10.1093/neuonc/noy148.761
NIMG-52. RADIATION-INDUCED VASCULAR MALFORMATIONS MIMICKING TUMOR IN MRI-BASED TREATMENT RESPONSE ASSESSMENT MAPS (TRAMs).
10.1093/neuonc/nox168.626
International Society for Therapeutic Ultrasound Conference 2016: Tel Aviv, Israel. 14-18 March, 2016.
10.1186/s40349-016-0079-2
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.
10.1136/bjophthalmol-2020-316613
Non-Invasive Low Pulsed Electrical Fields for Inducing BBB Disruption in Mice—Feasibility Demonstration
10.3390/pharmaceutics13020169
